1021882

Paul W. Crawford, MD — FEI 3010625404

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 7, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Chicago, IL (United States)

Additional Details

Clinical Investigator (CI)